Patient Support
"I'm so glad that I got diagnosed and treated for my symptoms of narcolepsy. It's really made a difference in my life." - Nicole Jeray, LPGA golfer & narcolepsy patient
Patient Advocacy
We provide continuing support to healthcare advocacy groups and scientific organizations. We collaborated with the Narcolepsy Network to produce a national public service campaign, educational brochures and DVDs distributed through physician offices to help raise awareness of this troubling sleep-wake disorder. We also support the efforts of the Anxiety Disorders Association of America to promote public and professional awareness of the enormous impact that anxiety disorders have on the lives of patients and their family and friends.
Patient Assistance
Jazz Pharmaceuticals currently provides Patient Assistance for U.S. patients.
Xyrem® (sodium oxybate) oral solution:
Reimbursement assistance is available for U.S. patients who are uninsured or underinsured, through the XYREM Success Program®. For more information and an application, please call 1-866-XYREM88 (
Co-pay assistance is available through a point-of-sale rebate card which provides patients up to $25 off of their out-of-pocket prescription or co-payment costs at the pharmacy.
Click for restrictions of use.
Please visit the www.LuvoxCR.com website for more information.
Patient Resources
We are committed to supporting and providing resources for the patients who inspire us. Because cognitive behavioral therapy (CBT) can be an important part of a comprehensive treatment plan for patients with obsessive compulsive disorder (OCD), Jazz Pharmaceuticals supported the development of CT STEPS™.
CT STEPS is a program designed for OCD patients by Dr. John Greist and his colleagues, Dr. Lee Baer and Dr. Isaac Marks. It was originally created as a phone-based program for OCD, but through the use of the internet, it has now been made into an interactive tool that is accessible 24 hours a day to help patients monitor their own progress confidentially.
CT STEPS is not designed to replace behavioral therapists. Instead, it is designed to provide a service for use in addition to behavioral therapy or for patients who may not have access to behavioral therapy. CT STEPS has not been studied in combination with pharmacotherapy. Click here to visit the CT STEPS website at www.CTSTEPS.com.
Inside Jazz Pharma
I like that we put patients FIRST and in doing so, change the attitudes of some health care providers as to how they view companies within our industry. We can and should go back to being an important resource to the health care providers in improving patient care and outcomes.Allan Regional Sales Manager